Last
Update:
December 08, 2014
 Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader'
5th IAS Conference on
HIV Pathogenesis, Treatment
and Prevention |
- POSTER
The evolution of co-receptor
tropism in patients interrupting suppressive HAART
L. Waters, A. Scourfield, M. Marcano, et al
PDF Poster
Abstract
- POSTER
Lipopolysaccharide (LPS)
changes in plasma of HIV-1-infected subjects during repeated treatment
interruptions
L. Palmisano, S. Baroncelli, C.M. Galluzzo, et al
PDF Poster
Abstract
-
POSTER
Impact of HAART interruption on plasma inflammatory markers associated with
cardiovascular
disease. Final 36-month results from a randomized study
M.M. Olmo, C. Alonso-Villaverde, M. Peñaranda, et al
PDF Poster
Abstract
-
Specific anti-gag
immune response during and after structured treatment interruption
C. Mussini, E. Nemes, E. Lugli
Abstract
A 2-Months-off/4-Months-on HAART
Is Clinically Not Inferior to Continuous Therapy but Leads
to Unacceptable Resistance Rates in African Adults with >350
CD4/mm3 at First Interruption:
Final Results of the Trivacan Trial
C Danel, R Moh,
ML Chaix, et al
PDF Poster Abstract
Impact of resistance and structured treatment interruption (STI) on response
to salvage antiretroviral
(ARV) therapy
Thorne A., Harrigan R., Lapierre N., et al
Abstract
HIV-specific T cell responses in chronic paediatric infection during
antiretroviral therapy (continuous
and structured treatment interruption)
Reddy S.
Abstract
Structured treatment interruptions: a pilot study
Tupinambás U., Westin M., Alvares J., et al
Abstract
The
impact of a structured treatment interruption (STI) on the tolerability of a
salvage antiretroviral
(ARV) regimen in patients
with virologic failure
Walmsley S., Lapierre N., Woods R., et al
Abstract
Time
to HAART resume after structured treatment interruption is strongly associated
with HIV DNA
level in PBMC at interruption: results of the ANRS 116 SALTO
trial
Piketty C., Weiss L., Bachir-Cherif S., et al
Abstract
Absence of sustained benefit of HAART followed by structured treatment
interruptions (STI) in primary
HIV-1 infection (PHI): prolonged follow-up of
patients enrolled in the PRIMSTOP (ANRS 100) trial
Hoen B., Deveau C., Fournier I., et al
Abstract
Structured treatment interruption in HIV-infected children and adolescents:
risks and benefits
Rubini N.P.M., Llerena C.L.A., Brindeiro P., et al
Abstract
4th IAS Conference on
HIV Pathogenesis, Treatment
and Prevention |
Gordin F, Roediger M, Clezy K, et al
Abstract
Frequency, causes, and factors associated with treatment
interruptions (TI) among adults initiating
highly active antiretroviral therapy (HAART) in Western Kenya
Braitstein P. , Mwangi A, Wools-Kaloustian
K, et al
Abstract
PBMC and plasma genotypic resistance during CD4-guided HAART
interruption in patients receiving
mainly NNRTI-based regimens
Olmo M, Podzamczer D, Niubó J, et al
Abstract
Evolution of antiretroviral resistance in Ugandan patients on
first-line HAART with persistent virologic failure
Reynolds S, Dybul M, Daucher M, et al
Abstract
Supersensitive viral load assay to predict incomplete viral
suppression during STI-re-treatment cycles
Langford S, Gayet-Ageron A, Duncombe C
Abstract
Patient reported symptoms improve following prolonged treatment
interruption: ACTG 5170 quality of
life results
Skiest D., Krambrink A, Su Z, et al
Abstract
Dynamics of mutations during treatment
interruption after successfully HAART-regimens
Prati F , Ceccherini-Silberstein F , Nasi M , et
al
Abstract
Low human immunodeficiency virus envelope divergence is
associated with undetectable levels
of plasma viremia and the absence of genotypic resistance during
short-cycle treatment interruptions
Daucher M, Heath L, Kraske E, et al
Abstract
Determinants of immunological response to HAART resumption after
treatment interruption in HIV-1
clinical practice
Touloumi G, Pantazis N, Stirnadel HA, et al
Abstract
Determinants of immunologic response following HAART resumption
after 1 cycle of CD4-guided
treatment interruption
Mussini C, Touloumi G, Bakoyiannis G, et
al
Abstract
|
5th
IAS Conference
XVI
International AIDS Conference
Archived
Conference Citations